BeStock  
Stocks › Biotechnology › VRDN

Viridian Therapeutics VRDN

US equityMarket cap rank #2344Biotechnology
$29.96 −$1.48 (-4.71%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $29.96 0.00%
Open$31.12
Prev close$31.44
Day range$29.87 – $31.75
Volume1.75M
Market cap$3.40B
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

VRDN at a glance

Viridian Therapeutics (VRDN) is trading at $29.96, down 4.71% on the day. Its market value of $3.40B makes it the 2344th largest of the 3753 companies we follow.

Over the past 52 weeks it has traded between $13.18 and $34.29, so it sits 12.6% below the top of that range. Holders are behind 1.3% over twelve months, but up 24.7% across the last three months.

On the chart it holds above both the 50-day ($23.53) and 200-day ($21.52) moving averages; RSI is 64, and the last 30 sessions moved at roughly 64% annualized volatility.

In the quarter ended Sep 2026 the company brought in $25.75M of revenue, down 63.5% from a year earlier, and a net loss of $101.21M.

8 analysts follow the stock and the average call is "buy". The mean target, $40.43, sits 34.9% over where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Bid / Ask$29.40 / $31.25
Average price today$30.49
Volume1.75MAvg (90d) 2.05M
Turnover$53.29M
Turnover rate1.77%of shares outstanding
Volume ratio0.82vs. recent average pace
Day amplitude5.98%
Market cap$3.40B
Float market cap$2.97B
Shares outstanding99.06M
EPS (TTM)-$3.32
P/B7.05
Book value / share$4.25
Net profit (TTM)-$377.01M
Net assets$482.62M
30-day volatility64.4%annualized
Avg daily range (ATR)5.52%of price, 14 days
Max drawdown (1y)-60.6%-11.3% from 1y peak

Quote as of Nov 20, 2026 8:10 pm ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

B
BeStock Grade

Composite of 3 factors below, ranked against the 3734 U.S. stocks BeStock covers.

A
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

B
Momentum

Trading closer to its 52-week high than most peers scores higher.

B
Wall Street

8 analysts, consensus Buy.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Six-factor research snapshot

Overall percentile: 51.2 · 2026-11-22 14:27 UTC. Higher values indicate a stronger relative ranking.

FactorPercentile
Valuation—
Growth—
Profitability4.6
Momentum77.7
Financial health68.6
Analyst view72.1

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$40.43+34.9% vs. current price
Consensus ratingBuy8 analysts covering
Morningstar fair value$42.91Price is below fair value

Wall Street’s average 12-month target is $40.43, 34.9% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $42.91, so shares trade 30.2% below that estimate. On earnings multiple, it sits in the 12th percentile of its own five-year valuation range (cheaper than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
-4.7%
1 week
-2.9%
1 month
+31.3%
3 months
+24.7%
6 months
+73.8%
Year to date
-3.7%
1 year
-1.3%
Day range
$29.87$31.75
52-week range
$13.18$34.29

Technical signals

Full technicals →
Trend readStrong uptrend

6 bullish · 1 bearish of 7 signals

IndicatorValueSignal
Price vs 20-day average+6.5%Bullish
Price vs 50-day average+27.3%Bullish
Price vs 200-day average+39.2%Bullish
50-day vs 200-day50d above 200dBullish
RSI (14)64.0Bullish
MACD (12,26,9)2.23Bearish
Bollinger band position66%Bullish

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How VRDN ranks on BeStock

Market value#2335 of 3734
Closeness to 52-week high#867 of 3724
Dollar volume today#1377 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

VRDN is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on VRDN.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on VRDN

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

VRDN stock: common questions

How is Viridian Therapeutics stock doing today?

$29.96 is the latest print for VRDN, a move of -4.71% against yesterday's close of $31.44. Today's low and high so far: $29.87 and $31.75.

What is VRDN worth in total?

Equity value comes to $3.40B at the current price. By that measure it is number 2344 of the 3753 names in our coverage.

Is VRDN near its 52-week high or low?

The year's floor is $13.18 and the ceiling $34.29. Shares are 12.6% away from that ceiling.

Does Viridian Therapeutics pay a dividend?

Our data shows no dividend paid by Viridian Therapeutics over the trailing twelve months.

Is VRDN rated a buy by Wall Street?

Of 8 analysts, 100% say buy, 0% hold and 0% sell. Price targets average $40.43, with the most cautious at $33.00 and the most optimistic at $53.00.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on VRDN.

Sign in to join the discussion.

Scroll to Top